Czechs beef up investment in biotech research

The Czech Republic is substantially boosting its investment in biotechnology research, with plans to build a massive research center near Prague set to employ 600 people, the Prague Daily Monitor is reporting. Plans call for spending 2.4 billion crowns (more than $120 million U.S.) on the project, with the investment drawn from EU funds. It will take two years to finish building the complex, which will focus on new drug development, tissue engineering and diagnostics, among other areas. The government plans to pay the researchers high wages and will cover international moving expenses. Construction should start by year-end, according to the article. Story

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.